Arnold & Porter announced today that David Henry, a practicing UK barrister and Belgian advocaat, has joined the firm’s Antitrust & Competition practice as counsel, resident in Brussels.
Mr. Henry, who brings with him more than a decade of antitrust experience, advises across the full spectrum of EU antitrust/competition matters, including cartel defense, abuse of dominance, merger control, distribution, and the interaction between antitrust and intellectual property. He has represented companies across a wide range of industries, including, but not limited to, pharmaceuticals and technology. Mr. Henry has extensive experience in representing international companies before the European Commission and in multi-jurisdictional matters. He has also advised various international companies in merger control proceedings and in litigation before national regulators and courts.
Fluent in French and German, Mr. Henry is a visiting lecturer on advanced EU competition law at the University of Liège in Belgium, and at the College of Europe in Belgium on EU competition policy and high-tech markets.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan